Scientists have created the first ever viruses designed by artificial intelligence (AI), and they’re capable of hunting down and killing strains of Escherichia coli (E. coli). “This is the first time ...

The original version of this story appeared in Quanta Magazine. Imagine that someone gives you a list of five numbers: 1, 6, 21, 107, and—wait for it—47,176,870. Can you guess what comes next? If ...

Listen to more stories on the Noa app. Harris started looking for his first real job months before his graduation from UC Davis this spring. He had a solid résumé, he thought: a paid internship at a ...

Ensuring communications sent to state and local government agency clients are clear and understandable is crucial to ensure that individuals and families receive the services they need. Social ...

Gen Z knows using a chatbot to write a whole essay is wrong. But what are they supposed to use it for? Rachel Janfaza is the founder of Up and Up Strategies, a research and consulting firm focused on ...

17-old-old Chicago rapper BabyChiefDoIt claims that his recent comments about using ChatGPT for lyrics was taken out of context. On Aug. 11, the "Went West" artist visited Power 105.1, where, around ...

More than a dozen House Democrats pressed Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz in a letter last week over CMS's announced plans to expand prior authorization ...

I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...

The gaming world rarely sleeps, but when it erupts in controversy, the ripple effects can be felt across every corner of the internet. Enter PeterBot, the 18-year-old Fortnite prodigy whose career ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...